This site is intended for health professionals only

At the heart of general practice since 1960

pulse june2020 80x101px
Read the latest issue online

GPs go forth

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Using a glitazone second-line in diabetes 'reduces mortality by 30%'


It is a bit of Choose and Book situation : One school is very keen on pioglitazone and considers that it was flawed the way those side effects were reported . The other school is certainly looking at banning glitazones. Between glitazones and gliptins , the former is more potent on HBA1c as the latter only lowers the value by 0.75%.......

Posted date

09 Nov 2012

Posted time